Héphaïstos is a software company that can help pathologists and cytology technicians make faster, more informed diagnosis and treatment decisions by extracting cancer care data.
Héphaïstos aims to provide an answer to one of the main questions in cancer screening: the dearth of pathologists. In both developing and developed countries, the dearth of pathologists can cause a workload and affect the performance of pathologists.
For example, in France, we have 2.2 pathologists per 100,000 inhabitants. In sub-Saharan Africa, a pathologist serves millions of people.
Our short-term strategy is to provide a series of modules that will allow pathologists to improve the scalability of their work, thereby providing better care at lower cost.
Our medium-term strategy is to provide a series of modules to enable cytologists to improve the scalability of their work. This allows better care at lower cost.
Our long-term strategy is to develop prognostic tools that integrate computer pathology with electronic health records, genomics and other clinical data to provide clinicians with layers of information to better optimize patient care.